Healthcare provider profile · identity verified

Chenyi Jeffrey Chenyi, MD

Family Practice · RUSSELLVILLE, AL · NPI 1922387299

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	242	18
Omeprazole	Omeprazole	217	11
Metoprolol Tartrate	Metoprolol Tartrate	141	suppressed
Eliquis	Apixaban	136	11
Losartan Potassium	Losartan Potassium	132	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	128	suppressed
Furosemide	Furosemide	123	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	117	suppressed
Divalproex Sodium	Divalproex Sodium	113	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	110	29
Buspirone Hcl	Buspirone Hcl	109	suppressed
Gabapentin	Gabapentin	106	36
Hydrochlorothiazide	Hydrochlorothiazide	98	suppressed
Duloxetine Hcl	Duloxetine Hcl	97	suppressed
Donepezil Hcl	Donepezil Hcl	95	suppressed
Montelukast Sodium	Montelukast Sodium	95	suppressed
Propranolol Hcl	Propranolol Hcl	91	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	84	suppressed
Calcium Acetate	Calcium Acetate	82	suppressed
Potassium Chloride	Potassium Chloride	82	11
Atorvastatin Calcium	Atorvastatin Calcium	81	suppressed
Metoprolol Succinate	Metoprolol Succinate	80	suppressed
Metformin Hcl	Metformin Hcl	74	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	71	suppressed
Clonidine Hcl	Clonidine Hcl	69	suppressed
Finasteride	Finasteride	69	suppressed
Amiodarone Hcl	Amiodarone Hcl	68	suppressed
Pravastatin Sodium	Pravastatin Sodium	62	suppressed
Midodrine Hcl	Midodrine Hcl	60	suppressed
Glimepiride	Glimepiride	56	suppressed
Rivastigmine	Rivastigmine Tartrate	56	suppressed
Sucralfate	Sucralfate	56	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	54	suppressed
Risperidone	Risperidone	53	suppressed
Clopidogrel	Clopidogrel Bisulfate	52	suppressed
Topiramate	Topiramate	52	suppressed
Clonazepam	Clonazepam	51	suppressed
Citalopram Hbr	Citalopram Hydrobromide	49	suppressed
Prednisone	Prednisone	49	44
Lovastatin	Lovastatin	48	suppressed
Allopurinol	Allopurinol	45	suppressed
Tramadol Hcl	Tramadol Hcl	44	19
Divalproex Sodium Er	Divalproex Sodium	43	suppressed
Olanzapine	Olanzapine	43	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	43	suppressed
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	42	suppressed
Valsartan	Valsartan	41	suppressed
Hydrocortisone	Hydrocortisone	38	suppressed
Tradjenta	Linagliptin	38	suppressed
Alprazolam	Alprazolam	35	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Azithromycin	Azithromycin	30	29
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Sertraline Hcl	Sertraline Hcl	26	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Simvastatin	Simvastatin	24	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Famotidine	Famotidine	19	suppressed
Ibuprofen	Ibuprofen	19	19
Digoxin	Digoxin	18	suppressed
Levofloxacin	Levofloxacin	18	17
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Cefdinir	Cefdinir	15	14
Humulin R	Insulin Regular, Human	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Rosuvastatin Calcium	Rosuvastatin Calcium	14	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Nuplazid	Pimavanserin Tartrate	12	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error